(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -17.59%28.04B | ---- | 30.71%34.02B | ---- | 5.48%26.03B | ---- | 3.75%24.68B | ---- | 1.52%23.78B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 41.97%-11.71B | ---- | -12.14%-20.18B | ---- | -1.62%-18B | ---- | -4.26%-17.71B | ---- | -2.12%-16.99B |
Investment loss (gain) | ---- | -210.01%-4.08B | ---- | --3.71B | ---- | ---- | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | -15.76%-5.53B | ---- | -5.59%-4.78B | ---- | -14.50%-4.52B | ---- | 7.04%-3.95B | ---- | 5.18%-4.25B |
Impairment and provisions: | ---- | 633.90%433M | ---- | -84.72%59M | ---- | 241.59%386M | ---- | -15.67%113M | ---- | 129.52%134M |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | 4.42%118M | ---- | -51.50%113M | ---- | 163.49%233M |
-Other impairments and provisions | ---- | 633.90%433M | ---- | -77.99%59M | ---- | --268M | ---- | ---- | ---- | -13.79%-99M |
Asset sale loss (gain): | ---- | 6.78%-110M | ---- | -6.31%-118M | ---- | -56.34%-111M | ---- | -108.82%-71M | ---- | -105.11%-34M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 6.78%-110M | ---- | -6.31%-118M | ---- | -56.34%-111M | ---- | -108.82%-71M | ---- | 52.11%-34M |
Depreciation and amortization: | ---- | 0.89%3.75B | ---- | 6.32%3.72B | ---- | -1.22%3.5B | ---- | 6.15%3.54B | ---- | 80.41%3.33B |
-Depreciation | ---- | -6.81%1.83B | ---- | 6.38%1.97B | ---- | -3.65%1.85B | ---- | 1.91%1.92B | ---- | 12.28%1.88B |
-Amortization of intangible assets | ---- | 34.89%955M | ---- | 28.96%708M | ---- | 26.79%549M | ---- | 24.43%433M | ---- | --348M |
Financial expense | ---- | 14.53%1.15B | ---- | -34.44%1.01B | ---- | -0.90%1.53B | ---- | 8.64%1.55B | ---- | -31.34%1.42B |
Exchange Loss (gain) | ---- | 85.38%-111M | ---- | -369.15%-759M | ---- | -54.59%282M | ---- | 906.49%621M | ---- | 63.85%-77M |
Special items | ---- | ---- | ---- | 115.73%500M | ---- | -189.17%-3.18B | ---- | -202.75%-1.1B | ---- | -213.79%-363M |
Operating profit before the change of operating capital | ---- | -31.11%11.83B | ---- | 190.28%17.17B | ---- | -22.83%5.92B | ---- | 10.06%7.67B | ---- | -10.45%6.97B |
Change of operating capital | ||||||||||
Insurance business receivables (increase) decrease | ---- | ---- | ---- | ---- | ---- | -259.61%-5.39B | ---- | 129.61%3.38B | ---- | -166.85%-11.41B |
Insurance liabilities Increase (decrease) | ---- | -45.49%18.3B | ---- | 55.86%33.57B | ---- | 340.76%21.54B | ---- | -82.30%4.89B | ---- | 132.39%27.6B |
Reinsurance payable Increase (decrease) | ---- | ---- | ---- | ---- | ---- | -71.38%678M | ---- | -36.71%2.37B | ---- | 332.05%3.74B |
Special items for working capital changes | ---- | 22.45%-1.01B | ---- | 20.28%-1.31B | ---- | -939.49%-1.64B | ---- | -94.21%195M | ---- | -17.18%3.37B |
Cash from business operations | ---- | -41.10%29.12B | ---- | 134.24%49.44B | ---- | 14.13%21.11B | ---- | -38.91%18.49B | ---- | 69.76%30.27B |
Other taxs | ---- | -27.46%-8.58B | ---- | -41.06%-6.73B | ---- | 16.05%-4.77B | ---- | -27.25%-5.68B | ---- | 43.85%-4.47B |
Special items of business | 20.02%21.25B | ---- | -37.28%17.7B | ---- | 252.50%28.23B | ---- | -47.20%8.01B | ---- | 73.72%15.16B | ---- |
Net cash from operations | 20.02%21.25B | -51.90%20.54B | -37.28%17.7B | 161.45%42.71B | 252.50%28.23B | 27.52%16.34B | -47.20%8.01B | -50.35%12.81B | 73.72%15.16B | 161.21%25.81B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -25.09%6.53B | 14.25%14.8B | 17.83%8.71B | -31.99%12.95B | 12.94%7.39B | 27.30%19.05B | -10.54%6.55B | 6.96%14.96B | 0.12%7.32B | -2.27%13.99B |
Dividend received - investment | -33.17%2.9B | -9.53%6.68B | -6.12%4.34B | 57.78%7.38B | 144.92%4.62B | 19.56%4.68B | 15.05%1.89B | 15.06%3.91B | -1.03%1.64B | 10.46%3.4B |
Loan receivable (increase) decrease | ---- | ---- | ---- | -27.38%10.3B | -37.28%3.41B | -2.36%14.18B | 514.09%5.44B | --14.52B | 85.43%-1.31B | ---- |
Decrease in deposits (increase) | -685.07%-21.68B | 20,653.01%17.06B | -16.38%3.71B | 96.85%-83M | 588.53%4.43B | 59.80%-2.63B | 90.36%-907M | -168.43%-6.55B | -163.70%-9.41B | 175.54%9.57B |
Sale of fixed assets | 54.63%167M | 7.39%218M | 369.57%108M | -40.29%203M | -64.06%23M | 116.56%340M | --64M | 86.90%157M | ---- | -50.30%84M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --594M | --594M | ---- |
Acquisition of subsidiaries | ---- | ---980M | ---- | ---- | ---- | ---- | ---- | 85.61%-300M | -48.77%-2.36B | -2,027.55%-2.09B |
Recovery of cash from investments | 42.32%78.65B | -21.49%115.6B | -36.63%55.26B | 18.20%147.25B | 95.65%87.2B | 44.75%124.58B | -2.58%44.57B | -6.14%86.06B | 15.09%45.75B | 25.32%91.69B |
Cash on investment | -5.41%-82.22B | 20.94%-161.77B | 25.71%-78B | -23.32%-204.63B | -91.93%-104.99B | -24.78%-165.93B | 20.84%-54.7B | -18.84%-132.97B | -122.00%-69.1B | -38.08%-111.89B |
Other items in the investment business | -6.39%-849M | 50.85%-2.73B | 9.73%-798M | -130.16%-5.56B | -37.27%-884M | 75.29%-2.42B | 76.44%-644M | -156.49%-9.78B | -72.17%-2.73B | 32.63%-3.81B |
Net cash from investment operations | -147.50%-16.5B | 65.42%-11.13B | -653.28%-6.67B | -294.56%-32.19B | -46.47%1.21B | 72.24%-8.16B | 107.60%2.25B | -3,223.27%-29.39B | -246.82%-29.62B | 110.78%941M |
Net cash before financing | -57.00%4.75B | -10.55%9.41B | -62.50%11.04B | 28.66%10.52B | 186.90%29.43B | 149.33%8.18B | 170.97%10.26B | -161.99%-16.58B | -150.01%-14.45B | 2,231.82%26.75B |
Cash flow from financing activities | ||||||||||
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8B | --8B | ---- |
Interest paid - financing | 13.17%-554M | -18.59%-1.06B | 1.54%-638M | 49.69%-893M | 19.60%-648M | -58.06%-1.78B | -333.33%-806M | 32.39%-1.12B | 49.73%-186M | 12.76%-1.66B |
Dividends paid - financing | ---- | -17.44%-10.63B | ---- | -8.52%-9.05B | ---- | 18.65%-8.34B | ---- | -69.49%-10.25B | ---- | -20.71%-6.05B |
Absorb investment income | ---197M | ---- | ---- | -28.45%171M | -88.70%13M | -90.50%239M | --115M | --2.52B | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---15B | ---- | ---- | ---- | ---8B |
Other items of the financing business | 111.26%1.37B | -145.16%-1.67B | 46.10%-12.17B | -58.64%3.71B | -200.00%-22.58B | -26.99%8.96B | -246.49%-7.53B | 209.15%12.27B | 126.08%5.14B | -330.42%-11.24B |
Net cash from financing operations | 102.18%287M | -103.27%-14.22B | 44.06%-13.19B | 58.46%-7B | -174.29%-23.59B | -261.83%-16.85B | -168.22%-8.6B | 137.09%10.41B | 161.03%12.61B | -1,276.99%-28.06B |
Effect of rate | -94.35%7M | -84.24%49M | -34.04%124M | 380.18%311M | 454.72%188M | 29.75%-111M | -223.26%-53M | -495.00%-158M | 2,050.00%43M | --40M |
Net Cash | 333.07%5.03B | -236.48%-4.81B | -136.94%-2.16B | 140.67%3.53B | 252.26%5.84B | -40.47%-8.67B | 189.72%1.66B | -368.49%-6.17B | -122.42%-1.85B | -47.81%-1.32B |
Begining period cash | -22.41%16.49B | 22.03%21.25B | 22.03%21.25B | -33.51%17.41B | -33.51%17.41B | -19.46%26.19B | -19.46%26.19B | -3.78%32.52B | -3.78%32.52B | -2.57%33.8B |
Cash at the end | 12.03%21.53B | -22.41%16.49B | -18.05%19.22B | 22.03%21.25B | -15.66%23.45B | -33.51%17.41B | -9.49%27.8B | -19.46%26.19B | -26.95%30.71B | -3.78%32.52B |
Cash balance analysis | ||||||||||
Bank deposits | ---- | ---- | ---- | ---- | --11.29B | ---- | ---- | ---- | ---- | ---- |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | --11.29B | ---- | ---- | ---- | ---- | ---- |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership) | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership) | -- | PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership) | -- | Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership) | -- | Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data